The prognostic impact of epidermal growth factor receptor in patients with metastatic gastric cancer - Wikidata - wikimedia - TriplyDB

The prognostic impact of epidermal growth factor receptor in patients with metastatic gastric cancer

The prognostic impact of epidermal growth factor receptor in patients with metastatic gastric cancer

http://www.wikidata.org/entity/Q34478504

about

CD24 associates with EGFR and supports EGF/EGFR signaling via RhoA in gastric cancer cells.Single nucleotide polymorphisms in AREG and EREG are prognostic biomarkers in locally advanced gastric cancer patients after surgery with curative intent.Causes and consequences of microsatellite instability in gastric carcinogenesis.The significance of NTR1 expression and its correlation with β-catenin and EGFR in gastric cancer.EGF-Induced VEGF Exerts a PI3K-Dependent Positive Feedback on ERK and AKT through VEGFR2 in Hematological In Vitro Models.Prognostic value of diffuse versus intestinal histotype in patients with gastric cancer: a systematic review and meta-analysis.Latin America: ripe for cutting-edge research proposals for prevention and control of Helicobacter pylori.Effect of epidermal growth factor receptor status on the outcomes of patients with metastatic gastric cancer: A pilot study.RANKL/RANK pathway abrogates cetuximab sensitivity in gastric cancer cells via activation of EGFR and c-Src.EGFR protein expression and gene amplification in squamous intraepithelial lesions and squamous cell carcinomas of the cervix.Therapeutic targets associated to E-cadherin dysfunction in gastric cancer.The role of epidermal growth factor receptor in prognosis and treatment of gastric cancer.Nomograms predicting survival of patients with unresectable or metastatic gastric cancer who receive combination cytotoxic chemotherapy as first-line treatment.Targeted therapies in gastric cancer treatment: where we are and where we are going.Rab11-FIP2 promotes the metastasis of gastric cancer cells.Clinicopathologic and prognostic significance of human epidermal growth factor receptor in patients with gastric cancer: An updated meta-analysis Does the discrepancy in histologic differentiation between a forceps biopsy and an endoscopic specimen necessitate additional surgery in early gastric cancer?Gene copy number gain of EGFR is a poor prognostic biomarker in gastric cancer: evaluation of 855 patients with bright-field dual in situ hybridization (DISH) method.Gene mutations in stool from gastric and colorectal neoplasia patients by next-generation sequencing.Gene mutations in stool from gastric and colorectal neoplasia patients by next-generation sequencing.The prognostic impact of EGFR, ErbB2 and MET gene amplification in human gastric carcinomas as measured by quantitative Real-Time PCR.Second-line treatments: moving towards an opportunity to improve survival in advanced gastric cancer?Prognostic significance and frequency of EGFR expression and amplification in surgically resected advanced gastric cancer.CT textural analysis of gastric cancer: correlations with immunohistochemical biomarkers

P2860

Q33711342-5F443658-DBB7-4312-8D0B-BC87FEE5DEA6 Q34308255-7DEBA957-B47E-405A-A7BA-ACB3C07091D6 Q34589660-B61116C3-507D-4DDC-B42B-9B1BAC940242 Q35895961-3A025C65-A06C-4737-80B1-BFA382AFBC89 Q36180362-B554F515-2E2D-464B-BBA2-02063232F969 Q36303653-25907101-D13B-47CE-A673-5D1239C2A817 Q36566269-F59FF5B1-AF24-4ED3-8C2A-03FCBFD5E4DD Q37388719-964FC54E-A671-4665-B5DD-4379B9102B34 Q37582762-BBF57381-CD06-49F6-92FB-4AA5BF2F2EE0 Q37587410-01511E50-766B-47EB-9CAD-1FC12C255F6E Q38129925-EB19F82E-A6FD-4539-B7B9-93B2CDE3EE88 Q38177325-FC2BED02-8573-47CC-A95C-2C197D89D100 Q38614739-1CF71685-DEFB-4609-A5E1-A0E6378EAC6D Q38731943-59CF8C0A-9CBE-4BE6-9C19-76DD441FE345 Q38824899-1100AF96-753F-4962-9D34-7A0CA4C50718 Q40332121-3E068469-C8F7-4E71-BA73-CECD7DEA5423 Q41447013-235DE74A-37E9-4251-A9AC-8BADE17FAE47 Q41714879-A9BF1AB4-E9D7-4110-B360-F0C1B729B201 Q47106128-C5A35A2A-ED4E-4235-95B1-6319846A35BE Q47200284-689AB0E2-3D58-4E11-987C-E2D8A54F437C Q53562884-6FFA8F24-442E-47AF-8FC6-C54319657B56 Q54970742-E7AA28FF-4111-4020-B76F-6537449F3070 Q55026328-7FDDEB5E-6CF3-4D59-9B30-FEC8C939DFE7 Q58797864-6F96A379-8810-481F-9285-CF2AFB9232CB

P2860

The prognostic impact of epidermal growth factor receptor in patients with metastatic gastric cancer

http://www.wikidata.org/entity/Q34478504

description

2012 nî lūn-bûn

@nan

2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

The prognostic impact of epide ...... with metastatic gastric cancer

@ast

The prognostic impact of epide ...... with metastatic gastric cancer

@en

The prognostic impact of epide ...... with metastatic gastric cancer

@nl

type

label

The prognostic impact of epide ...... with metastatic gastric cancer

@ast

The prognostic impact of epide ...... with metastatic gastric cancer

@en

The prognostic impact of epide ...... with metastatic gastric cancer

@nl

prefLabel

The prognostic impact of epide ...... with metastatic gastric cancer

@ast

The prognostic impact of epide ...... with metastatic gastric cancer

@en

The prognostic impact of epide ...... with metastatic gastric cancer

@nl

P1433

Q34478504-0CA9C007-376B-49F4-AE19-74E544DA6175

P1476

Q34478504-CFD9239C-A697-4061-803A-338FA760BA5B

P2093

Q34478504-003C3D43-FF0D-43EF-B665-DA55A229116C

Q34478504-4BDA5B09-1BEA-4A64-B91D-4961A11AC28C

Q34478504-667DB33E-4DC1-480E-BC57-43C22E36A80D

Q34478504-69A2B649-BFFD-4E9D-8F59-719FE288BDEB

Q34478504-76F16E25-D766-4037-869A-1A170F07EB6C

Q34478504-858C0819-3D1E-4D83-BFEA-4D73DC0D2F5F

Q34478504-A07C6839-2AD5-4943-A77E-B6B2D58021F1

Q34478504-A294077E-A1EB-46E6-B8CF-79550B8C8E90

P2860

Q34478504-102FC742-2CFD-468A-BC5D-E99C3B8A7923

Q34478504-1DC501B9-CA6F-4302-8F30-6BB628EACBD5

Q34478504-29CF1693-9BB2-4334-9D3E-8C8C78757488

Q34478504-356C6F06-2E72-44AF-956D-4829EB9F665D

Q34478504-438A9482-B67B-425C-A527-594EB41706C6

Q34478504-46E5B66E-064F-42A7-85B4-D6C3FC6A6779

Q34478504-517F4DC8-FAD5-4D60-BBD7-EFED83932F89

Q34478504-66907667-1166-480B-BC1D-41CC71AD487A

Q34478504-6A585F82-8E50-4F0D-BCB1-EB6398AEEDEB

Q34478504-792D4D2C-9C8F-454B-903B-223249D21C2C

P2888

Q34478504-AFEDD833-28CF-4816-831F-0D1771EDE8CA

P304

Q34478504-98BBB0FC-B55F-416A-9521-8ACA9C0F1CB9

P31

Q34478504-171B0F00-744C-42F5-BC17-64ADC2A81FDD

P356

Q34478504-E6946C49-DD55-43E2-ACBC-8610C1445127

P407

Q34478504-E872E29B-9348-4688-922A-448F0BA25FCB

P478

Q34478504-7A0C9323-823E-49E3-94AC-246A94B4CB0F

P577

Q34478504-433CA2B6-8432-41CE-8618-0285E5D66759

P5875

Q34478504-965DCB26-E480-4ADA-BC45-AFF09EBFB327

P6179

Q34478504-98955B86-08DC-4403-8097-F9ECC4E851B8

P698

Q34478504-A8C3A1EB-2DB1-4E64-905A-279F74EBABDF

P921

Q34478504-EA1B0CFB-1FCE-4CD5-8B54-93F299217262

P932

Q34478504-39932E7C-464D-467F-9DB9-5ED0561731F1

P356

1471-2407-12-524

P1433

P1476

The prognostic impact of epide ...... with metastatic gastric cancer

@en

P2093

Akin Atmaca

http://www.w3.org/2001/XMLSchema#string

Claudia Pauligk

http://www.w3.org/2001/XMLSchema#string

Dominique Werner

http://www.w3.org/2001/XMLSchema#string

Elke Jäger

http://www.w3.org/2001/XMLSchema#string

Hans-Michael Altmannsberger

http://www.w3.org/2001/XMLSchema#string

Kristina Steinmetz

http://www.w3.org/2001/XMLSchema#string

Ralph Wirtz

http://www.w3.org/2001/XMLSchema#string

Salah-Eddin Al-Batran

http://www.w3.org/2001/XMLSchema#string

P2860

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

Impacts of excision repair cross-complementing gene 1 (ERCC1), dihydropyrimidine dehydrogenase, and epidermal growth factor receptor on the outcomes of patients with advanced gastric cancer.

Prognostic significance of immunohistochemical expression of EGFR and C-erbB-2 oncoprotein in curatively resected gastric cancer.

DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy.

Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group.

Biweekly fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) for patients with metastatic adenocarcinoma of the stomach or esophagogastric junction: a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie.

Biomarker analysis in stage III-IV (M0) gastric cancer patients who received curative surgery followed by adjuvant 5-fluorouracil and cisplatin chemotherapy: epidermal growth factor receptor (EGFR) associated with favourable survival.

Targeting the human EGFR family in esophagogastric cancer.

RNA extraction from archival formalin-fixed paraffin-embedded tissue: a comparison of manual, semiautomated, and fully automated purification methods.

P2888

1471-2407-12-524

P304

524

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-12-524

http://www.w3.org/2001/XMLSchema#string

P407

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2012-11-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233422525

http://www.w3.org/2001/XMLSchema#string

P6179

1010937785

http://www.w3.org/2001/XMLSchema#string

P698

23153332

http://www.w3.org/2001/XMLSchema#string

P921

P932

3529672

http://www.w3.org/2001/XMLSchema#string